Yew Bio-Pharm Group, Inc.
YEWB · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $7 | $10 | $6 | $6 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $9 | $10 | $9 | $9 |
| Enterprise Value | $17 | $19 | $15 | $14 |
| Revenue | $0 | $15 | $9 | $5 |
| % Growth | -99.3% | 69.9% | 63% | – |
| Gross Profit | -$1 | -$0 | $1 | $0 |
| % Margin | -763% | -1.5% | 11% | 5.1% |
| EBITDA | -$0 | $0 | $3 | $1 |
| % Margin | -306.6% | 2% | 34% | 14.8% |
| Net Income | -$2 | -$1 | $3 | -$0 |
| % Margin | -1,569% | -3.7% | 33.4% | -7.8% |
| EPS Diluted | -0.033 | -0.011 | 0.06 | -0.008 |
| % Growth | -215.1% | -117.7% | 840.7% | – |
| Operating Cash Flow | $6 | $2 | -$1 | $5 |
| Capital Expenditures | -$11 | -$0 | -$2 | -$6 |
| Free Cash Flow | -$5 | $2 | -$2 | -$1 |